Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
209.32
+3.97 (1.93%)
Feb 11, 2026, 4:00 PM EST - Market closed
Quest Diagnostics Employees
Quest Diagnostics had 56,000 employees as of December 31, 2024. The number of employees increased by 8,000 or 16.67% compared to the previous year.
Employees
56,000
Change (1Y)
8,000
Growth (1Y)
16.67%
Revenue / Employee
$197,054
Profits / Employee
$17,643
Market Cap
23.03B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 56,000 | 8,000 | 16.67% |
| Dec 31, 2023 | 48,000 | -1,000 | -2.04% |
| Dec 31, 2022 | 49,000 | 0 | - |
| Dec 31, 2021 | 49,000 | 0 | - |
| Dec 31, 2020 | 49,000 | 2,000 | 4.26% |
| Dec 31, 2019 | 47,000 | 1,000 | 2.17% |
| Dec 31, 2018 | 46,000 | 1,000 | 2.22% |
| Dec 31, 2017 | 45,000 | 2,000 | 4.65% |
| Dec 31, 2016 | 43,000 | -1,000 | -2.27% |
| Dec 31, 2015 | 44,000 | -1,000 | -2.22% |
| Dec 31, 2014 | 45,000 | 4,000 | 9.76% |
| Dec 31, 2013 | 41,000 | 0 | - |
| Dec 31, 2012 | 41,000 | -1,000 | -2.38% |
| Dec 31, 2011 | 42,000 | 0 | - |
| Dec 31, 2010 | 42,000 | -1,000 | -2.33% |
| Dec 31, 2009 | 43,000 | 200 | 0.47% |
| Dec 31, 2008 | 42,800 | -700 | -1.61% |
| Dec 31, 2007 | 43,500 | 2,500 | 6.10% |
| Dec 31, 2006 | 41,000 | -500 | -1.20% |
| Dec 31, 2005 | 41,500 | 2,900 | 7.51% |
| Dec 31, 2004 | 38,600 | 1,400 | 3.76% |
| Dec 31, 2003 | 37,200 | 3,800 | 11.38% |
| Dec 31, 2002 | 33,400 | 4,400 | 15.17% |
| Dec 31, 2001 | 29,000 | 2,000 | 7.41% |
| Dec 31, 2000 | 27,000 | 0 | - |
| Dec 31, 1999 | 27,000 | 12,000 | 80.00% |
| Dec 31, 1998 | 15,000 | -1,300 | -7.98% |
| Dec 31, 1997 | 16,300 | -1,500 | -8.43% |
| Dec 31, 1996 | 17,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| IQVIA Holdings | 88,000 |
| Labcorp Holdings | 70,000 |
| Mettler-Toledo International | 18,100 |
| Agilent Technologies | 18,100 |
| Revvity | 11,000 |
| Illumina | 10,370 |
| Waters | 7,600 |
| Exact Sciences | 7,000 |
DGX News
- 1 day ago - Quest Diagnostics Incorporated (DGX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Quest Diagnostics forecasts 2026 profit, revenue above estimates on lab test demand - Reuters
- 1 day ago - Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share - PRNewsWire
- 1 day ago - Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization - PRNewsWire
- 1 day ago - The Great AI Squeeze: High Costs Take Center Stage In Hyperscalers' Earnings Reports - Seeking Alpha
- 9 days ago - Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease - PRNewsWire
- 14 days ago - Quest Diagnostics: A Continuing Bullish Case For A Leader Among Diagnostic Testing Brands - Seeking Alpha
- 21 days ago - Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year - PRNewsWire